Pacific Biosciences of California
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $36,013 | $38,810 | $58,357 | $55,691 |
Gross Profit | 3,685 | 4,429 | 11,004 | 17,902 |
EBITDA | -50,329 | -69,418 | -86,385 | -64,538 |
EBIT | -64,618 | -81,432 | -104,241 | -69,993 |
Net Income | -173,319 | -78,178 | -82,018 | -66,869 |
Net Change In Cash | 36,013 | 38,810 | 58,357 | 55,691 |
Free Cash Flow | -55,742 | -79,561 | -59,634 | -66,011 |
Cash | 99,868 | 76,946 | 180,211 | -43,560 |
Basic Shares | 272,385 | 269,578 | 267,120 | 255,001 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $200,521 | $128,304 | $130,513 | $78,893 |
Gross Profit | 40,345 | 49,035 | 58,860 | 32,566 |
EBITDA | -277,674 | -297,181 | -178,070 | -102,330 |
EBIT | -310,365 | -314,499 | -189,655 | -111,634 |
Net Income | -306,735 | -296,930 | -181,223 | 29,403 |
Net Change In Cash | 200,521 | 128,304 | 130,513 | 78,893 |
Cost of Revenue | 379,870 | 52,020 | ||
Free Cash Flow | -275,391 | -280,140 | -117,111 | 18,464 |
Cash | 180,211 | 325,089 | 460,725 | 318,814 |
Basic Shares | 253,629 | 224,550 | 204,136 | 174,970 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.64 |
2024-03-31 | -$0.29 |
2023-12-31 | -$0.31 |
2023-09-30 | -$0.26 |
